Literature DB >> 14697864

The use of animal models in developing the discipline of cardiovascular tissue engineering: a review.

S Tawqeer Rashid1, Henryk J Salacinski, George Hamilton, Alexander M Seifalian.   

Abstract

Cardiovascular disease remains one of the major causes of death and disability in the Western world. Tissue engineering offers the prospect of being able to meet the demand for replacement of heart valves, vessels for coronary and lower limb bypass surgery and the generation of cardiac tissue for addition to the diseased heart. In order to test prospective tissue-engineered devices, these constructs must first be proven in animal models before receiving CE marking or FDA approval for a clinical trial. The choice of animal depends on the nature of the tissue-engineered construct being tested. Factors that need to be considered include technical requirements of implanting the construct, availability of the animal, cost and ethical considerations. In this paper, we review the history of animal studies in cardiovascular tissue engineering and the uses of animal tissue as sources for tissue engineering.

Entities:  

Mesh:

Year:  2004        PMID: 14697864     DOI: 10.1016/s0142-9612(03)00522-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  25 in total

Review 1.  Development of small-diameter vascular grafts.

Authors:  Xinwen Wang; Peter Lin; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 2.  Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review.

Authors:  Sandip Sarkar; Thomas Schmitz-Rixen; George Hamilton; Alexander M Seifalian
Journal:  Med Biol Eng Comput       Date:  2007-03-06       Impact factor: 2.602

3.  Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research.

Authors:  Leen Trommelmans; Joseph Selling; Kris Dierickx
Journal:  Med Health Care Philos       Date:  2009-07-24

Review 4.  [Tissue engineering of heart valves].

Authors:  P Akhyari; P Minol; A Assmann; M Barth; H Kamiya; A Lichtenberg
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

5.  Predicting in vivo responses to biomaterials via combined in vitro and in silico analysis.

Authors:  Matthew T Wolf; Yoram Vodovotz; Stephen Tottey; Bryan N Brown; Stephen F Badylak
Journal:  Tissue Eng Part C Methods       Date:  2014-08-04       Impact factor: 3.056

6.  An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia.

Authors:  Heather L Prichard; Roberto J Manson; Louis DiBernardo; Laura E Niklason; Jeffrey H Lawson; Shannon L M Dahl
Journal:  J Cardiovasc Transl Res       Date:  2011-07-12       Impact factor: 4.132

7.  Use of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal model.

Authors:  Alexandra E Jantzen; Whitney O Lane; Shawn M Gage; Ryan M Jamiolkowski; Justin M Haseltine; Lauren J Galinat; Fu-Hsiung Lin; Jeffrey H Lawson; George A Truskey; Hardean E Achneck
Journal:  Biomaterials       Date:  2011-08-15       Impact factor: 12.479

8.  Elucidating the role of graft compliance mismatch on intimal hyperplasia using an ex vivo organ culture model.

Authors:  Allison Post; Patricia Diaz-Rodriguez; Bailey Balouch; Samantha Paulsen; Siliang Wu; Jordan Miller; Mariah Hahn; Elizabeth Cosgriff-Hernandez
Journal:  Acta Biomater       Date:  2019-03-14       Impact factor: 8.947

9.  Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering.

Authors:  Peter M Crapo; Yadong Wang
Journal:  Acta Biomater       Date:  2009-11-01       Impact factor: 8.947

10.  Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Authors:  Jason D Roh; Gregory N Nelson; Matthew P Brennan; Tamar L Mirensky; Tai Yi; Tyrone F Hazlett; George Tellides; Albert J Sinusas; Jordan S Pober; W M Saltzman; Themis R Kyriakides; Christopher K Breuer
Journal:  Biomaterials       Date:  2007-12-27       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.